Brief: Adherium Says Astrazeneca Selected Co's Hailie Smartinhaler Platform For Clinical Trial
May 24 (Reuters) - Adherium Ltd ADR.AX :
* ASTRAZENECA HAS SELECTED CO'S HAILIE SMARTINHALER PLATFORM
FOR
CLINICAL TRIAL
* CONTRACT IS VALUED AT A$1.1M OVER COURSE OF 3 YEARS
Further company coverage: ADR.AX
((Reuters.Briefs@thomsonreuters.com;;))